NYSE
$8.71▼ 0.23%vs prev close
🔒 Quotes & buy pressure are MAX onlySee plans
Market cap $352.6MShares out 40.5M sh
Chart
Filings & news by date
Hover (PC) or tap (mobile) a candle to see that day only
Filings
14- 10.15After-hours26.10.16 05:378-KKey event#●●●
Orion Group Holdings Inc
Orion Group Holdings entered into a new employment agreement with CFO Alison G. Vasquez, effective October 12, 2026, replacing her previous offer letter. The agreement sets an annual base salary of $480,000 with a target annual bonus of 75% of base salary. It also includes severance provisions, such as three years of salary and bonus continuation and accelerated equity vesting, in the event of termination following a change in control.…more
$8.71-0.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUSView filingShare
- 10.9After-hours26.10.10 05:02SCHEDULE 13GOwnership
Orion Group Holdings Inc
Wasatch Advisors LP has filed a Schedule 13G, disclosing its beneficial ownership of more than 5% of Orion Group Holdings Inc. This filing formalizes the investor's current stake in the company.…more
$8.71-0.23%vs prev closeView filingShare - 9.21After-hours26.09.22 05:198-KKey event
Orion Group Holdings Inc
Orion Group Holdings, Inc. entered into amendments on September 18, 2026, to extend the employment agreements for CEO Travis J. Boone and executive E. Chipman Earle through December 31, 2026. The agreements now include provisions for automatic annual 12-month renewals starting January 1, 2027.…more
$8.71-0.23%vs prev closeView filingShare
13 more filings
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report
News
GlobeNewswire- 10.15Pre-market26.10.15 21:00#●●●#●●●#●●●
Oryzon Genomics Strengthens Vafidemstat Patent Portfolio Globally
Oryzon Genomics has received new patent grants for its drug candidate vafidemstat in South Korea, Mexico, New Zealand, and the Philippines. This expansion strengthens the company's global intellectual property protection for its psychiatric and neurodevelopmental disorder treatment programs.…more
$8.71-0.23%vs prev closeDetected5m · 30m · 60m · Next dayPLUS
- 9.22Pre-market26.09.22 21:01
●●●●●●●● ●●●●● ●●●●●●
Orion Group Holdings announced that its management will participate in the 25th Annual D.A. Davidson Diversified Industrials & Services Conference. This event is a standard investor relations activity and does not provide new financial or operational catalysts.…more
$8.71-0.23%vs prev close - 9.10Pre-market26.09.10 21:00
●●●●●●●● ●●●●● ●●●●●●
Oryzon Genomics announced that its management will participate in several global investor conferences throughout September and October. This event participation is a standard corporate outreach activity and does not involve any new material contracts or financial results.…more
$8.71-0.23%vs prev close
2 more news items
Sign up free to unlock the full feed and real-time filing & news alerts.
- ✓Free — no card required
- ✓Full real-time filing & news feed
- ✓Daily Today Report